SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010416
Filing Date
2021-08-05
Accepted
2021-08-05 08:26:11
Documents
56
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q blph-20210630x10q.htm   iXBRL 10-Q 1172813
2 EX-31.1 blph-20210630xex31d1.htm EX-31.1 9845
3 EX-31.2 blph-20210630xex31d2.htm EX-31.2 9348
4 EX-32 blph-20210630xex32.htm EX-32 9107
  Complete submission text file 0001558370-21-010416.txt   5065678

Data Files

Seq Description Document Type Size
5 EX-101.SCH blph-20210630.xsd EX-101.SCH 38837
6 EX-101.CAL blph-20210630_cal.xml EX-101.CAL 29407
7 EX-101.DEF blph-20210630_def.xml EX-101.DEF 155709
8 EX-101.LAB blph-20210630_lab.xml EX-101.LAB 361735
9 EX-101.PRE blph-20210630_pre.xml EX-101.PRE 284008
10 EXTRACTED XBRL INSTANCE DOCUMENT blph-20210630x10q_htm.xml XML 850682
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36845 | Film No.: 211146463
SIC: 2834 Pharmaceutical Preparations